Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziwen Yu

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Analytical Chemistry|May 6, 2022
Concise Biothiol-Activatable HPQ-NBD Conjugate as a Targeted Theranostic Probe for Tumor CellsYan Zhang, Caiyun Liu, Weimin Sun, et al.
Translational Lung Cancer Research|June 15, 2026
Pulmonary ground-glass opacity associated with cystic airspace: clinicopathological features and aggressivenessZiwen Yu, Jianfu Li, Hongsheng Deng, et al.
Cancer Medicine|May 11, 2022
Dynamic monitoring serum tumor markers to predict molecular features of EGFR-mutated lung cancer during targeted therapyZhuxing Chen, Liping Liu, Feng Zhu, et al.
Medcomm|July 22, 2024
Development of a genome atlas for discriminating benign, preinvasive, and invasive lung nodulesPeng Liang, Minhua Peng, Jinsheng Tao, et al.
Translational Lung Cancer Research|January 10, 2022
Comparison of first-generation EGFR-TKIs (gefitinib, erlotinib, and icotinib) as adjuvant therapy in resected NSCLC patients with sensitive EGFR mutationsQihua He, Jun Liu, Xiuyu Cai, et al.
Chinese Medical Journal Pulmonary and Critical Care Medicine|August 22, 2024
Asian, regional, and national burdens of respiratory tract cancers and associated risk factors from 1990 to 2019: A systematic analysis for the global burden of disease study 2019Ran Zhong, Xiuyu Cai, Jianfu Li, et al.
Translational Lung Cancer Research|February 9, 2026
Prognostic factors of epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitor (TKI): a nationwide registry study in ChinaWenhua Liang, Peiling Chen, Jianfu Li, et al.
Neoplasia (New York, N.Y.)|June 8, 2024
Spatial whole exome sequencing reveals the genetic features of highly-aggressive components in lung adenocarcinomaJianfu Li, Shan Xiong, Ping He, et al.
The Lancet. Oncology|December 9, 2024
Deep learning using histological images for gene mutation prediction in lung cancer: a multicentre retrospective studyYu Zhao, Shan Xiong, Qin Ren, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Analytical Chemistry|May 6, 2022
Concise Biothiol-Activatable HPQ-NBD Conjugate as a Targeted Theranostic Probe for Tumor CellsYan Zhang, Caiyun Liu, Weimin Sun, et al.
Translational Lung Cancer Research|June 15, 2026
Pulmonary ground-glass opacity associated with cystic airspace: clinicopathological features and aggressivenessZiwen Yu, Jianfu Li, Hongsheng Deng, et al.
Cancer Medicine|May 11, 2022
Dynamic monitoring serum tumor markers to predict molecular features of EGFR-mutated lung cancer during targeted therapyZhuxing Chen, Liping Liu, Feng Zhu, et al.
Medcomm|July 22, 2024
Development of a genome atlas for discriminating benign, preinvasive, and invasive lung nodulesPeng Liang, Minhua Peng, Jinsheng Tao, et al.
Translational Lung Cancer Research|January 10, 2022
Comparison of first-generation EGFR-TKIs (gefitinib, erlotinib, and icotinib) as adjuvant therapy in resected NSCLC patients with sensitive EGFR mutationsQihua He, Jun Liu, Xiuyu Cai, et al.
Chinese Medical Journal Pulmonary and Critical Care Medicine|August 22, 2024
Asian, regional, and national burdens of respiratory tract cancers and associated risk factors from 1990 to 2019: A systematic analysis for the global burden of disease study 2019Ran Zhong, Xiuyu Cai, Jianfu Li, et al.
Translational Lung Cancer Research|February 9, 2026
Prognostic factors of epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitor (TKI): a nationwide registry study in ChinaWenhua Liang, Peiling Chen, Jianfu Li, et al.
Neoplasia (New York, N.Y.)|June 8, 2024
Spatial whole exome sequencing reveals the genetic features of highly-aggressive components in lung adenocarcinomaJianfu Li, Shan Xiong, Ping He, et al.
The Lancet. Oncology|December 9, 2024
Deep learning using histological images for gene mutation prediction in lung cancer: a multicentre retrospective studyYu Zhao, Shan Xiong, Qin Ren, et al.
Pageof 3